Skip to main content
OpenTrials
Completed

NCT Number: NCT05755763

Validity and Reliability of the Turkish St. Marks Incontinence Score

For the Turkish validity and reliability study of St.Mark's (Vaizey) Incontinence Score, which consists of 7 questions, it will be applied to 65 people diagnosed with anal incontinence after it is translated by translation-retranslation method.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Acibadem Atakent University Hospital

Istanbul, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • people with the complatint of anal incontinence
  • being volunteered to participate

Exclusion criteria

  • having difficulties in understanding and speaking Turkish

Treatment and study plan

Anal incontinence patients with St. Mark's Incontinence Score

Other

The scale was applied to the patients who applied to our clinic with the diagnosis of anal incontinence.

Primary outcomes

  1. Turkish Validation and Reliability of St. Mark's Incontinence Score

    Time frame: 1 month

    St. Mark's Incontinence Score which shows the disease severity of anal incontinence patients and is used in the follow-up of their recovery status. The Turkish validity and reliability study of Mark's incontinence score will be conducted and it will be translated into Turkish.

Sponsors and collaborators

Lead sponsor

Atlas University

Other

Registry information

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Mar 6, 2023
Registry last updated
Mar 23, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.